Skip to main content
medichelpline
Join Free
Back to Drug Index
General MedicationsFOR RX COMPOUNDINGGeneric

ERYTHROMYCIN

ERYTHROMYCIN

Standard Dose
100%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued

Key Takeaways

  • Primary indication: Marketing status: Discontinued
  • Approval overview ERYTHROMYCIN is listed in Drugs@FDA under application 050610 (NDA).
  • Marketing status: Discontinued Active ingredient ERYTHROMYCIN Form and strength POWDER;FOR RX COMPOUNDING - 100% Sponsor PADDOCK LLC Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview ERYTHROMYCIN is listed in Drugs@FDA under application 050610 (NDA). Marketing status: Discontinued Active ingredient ERYTHROMYCIN Form and strength POWDER;FOR RX COMPOUNDING - 100% Sponsor PADDOCK LLC Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.